https://www.selleckchem.com/products/t-5224.html
o higher among patients with higher baseline potassium level, heart failure, hypertension, and diabetes.Fast and accurate identification of inhibitors with potency against HCV NS5B polymerase is currently a challenging task. As conventional experimental methods is the gold standard method for the design and development of new HCV inhibitors, they often require costly investment of time and resources. In this study, we develop a novel machine learning-based meta-predictor (termed StackHCV) for accurate and large-scale identification of HC
Curtir
Comentario
Compartilhar
